Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-10-09

AUTHORS

K Yoshimura, I Yano, T Yamamoto, M Kawanishi, Y Isomoto, A Yonezawa, T Kondo, A Takaori-Kondo, K Matsubara

ABSTRACT

Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is used to suppress GvHD in patients undergoing hematopoietic stem cell transplantation (HCT). The purpose of this study was to construct a population pharmacokinetic and pharmacodynamic model in HCT patients for individualized MPA therapy. Blood samples were obtained from 49 HCT patients after starting MMF therapy. Population pharmacokinetic and pharmacodynamic parameters were obtained using the program NONMEM. MPA was described via a one-compartment model with a first-order elimination, and 30.9% of MPA glucuronide (MPAG) was found in the enterohepatic circulation. Inosine-5′-monophosphate dehydrogenase (IMPDH) activity was modeled as a maximal inhibitory model with a half-maximal inhibitory concentration (IC50) of 3.59 μg/mL against MPA concentrations. Simulations based on the obtained pharmacokinetic and pharmacodynamic parameters revealed that decreased creatinine clearance increases the MPAG concentration followed by an increased MPA concentration; therefore, IMPDH activity decreases. Diarrhea decreases the enterohepatic circulation of MPAG and consequently reduces MPA concentration. The IC50 for MPA exhibited a positive association with C-reactive protein. Dosage adjustment based on plasma MPA concentration is required especially for patients with renal dysfunction and/or diarrhea. More... »

PAGES

44-51

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2017.213

DOI

http://dx.doi.org/10.1038/bmt.2017.213

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1092132023

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28991252


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mycophenolic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411217.0", 
          "name": [
            "Department of Clinical Pharmacy and Education, Graduate School of Pharmaceutical Science, Kyoto University, Sakyo-ku, Kyoto, Japan", 
            "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshimura", 
        "givenName": "K", 
        "id": "sg:person.01046575103.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046575103.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Kobe University Hospital, Chuo-ku, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411102.7", 
          "name": [
            "Department of Clinical Pharmacy and Education, Graduate School of Pharmaceutical Science, Kyoto University, Sakyo-ku, Kyoto, Japan", 
            "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan", 
            "Department of Pharmacy, Kobe University Hospital, Chuo-ku, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yano", 
        "givenName": "I", 
        "id": "sg:person.01253561205.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253561205.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411217.0", 
          "name": [
            "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamamoto", 
        "givenName": "T", 
        "id": "sg:person.01300424310.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300424310.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411217.0", 
          "name": [
            "Department of Clinical Pharmacy and Education, Graduate School of Pharmaceutical Science, Kyoto University, Sakyo-ku, Kyoto, Japan", 
            "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawanishi", 
        "givenName": "M", 
        "id": "sg:person.0732346503.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732346503.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411217.0", 
          "name": [
            "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isomoto", 
        "givenName": "Y", 
        "id": "sg:person.014305050033.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014305050033.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411217.0", 
          "name": [
            "Department of Clinical Pharmacy and Education, Graduate School of Pharmaceutical Science, Kyoto University, Sakyo-ku, Kyoto, Japan", 
            "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yonezawa", 
        "givenName": "A", 
        "id": "sg:person.0703767356.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703767356.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kondo", 
        "givenName": "T", 
        "id": "sg:person.0666225507.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666225507.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takaori-Kondo", 
        "givenName": "A", 
        "id": "sg:person.0743352217.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743352217.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411217.0", 
          "name": [
            "Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsubara", 
        "givenName": "K", 
        "id": "sg:person.01303570015.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303570015.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s40620-016-0345-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026969484", 
          "https://doi.org/10.1007/s40620-016-0345-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01113502", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044213416", 
          "https://doi.org/10.1007/bf01113502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200746010-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003506752", 
          "https://doi.org/10.2165/00003088-200746010-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1012299115260", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050934479", 
          "https://doi.org/10.1023/a:1012299115260"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10928-007-9066-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023254119", 
          "https://doi.org/10.1007/s10928-007-9066-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-011-0888-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049134449", 
          "https://doi.org/10.1007/s12185-011-0888-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/s12248-011-9255-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035687095", 
          "https://doi.org/10.1208/s12248-011-9255-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.clpt.6100347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022424851", 
          "https://doi.org/10.1038/sj.clpt.6100347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-012-1086-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049970375", 
          "https://doi.org/10.1007/s12185-012-1086-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2014.258", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041000870", 
          "https://doi.org/10.1038/bmt.2014.258"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-10-09", 
    "datePublishedReg": "2017-10-09", 
    "description": "Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is used to suppress GvHD in patients undergoing hematopoietic stem cell transplantation (HCT). The purpose of this study was to construct a population pharmacokinetic and pharmacodynamic model in HCT patients for individualized MPA therapy. Blood samples were obtained from 49 HCT patients after starting MMF therapy. Population pharmacokinetic and pharmacodynamic parameters were obtained using the program NONMEM. MPA was described via a one-compartment model with a first-order elimination, and 30.9% of MPA glucuronide (MPAG) was found in the enterohepatic circulation. Inosine-5\u2032-monophosphate dehydrogenase (IMPDH) activity was modeled as a maximal inhibitory model with a half-maximal inhibitory concentration (IC50) of 3.59\u2009\u03bcg/mL against MPA concentrations. Simulations based on the obtained pharmacokinetic and pharmacodynamic parameters revealed that decreased creatinine clearance increases the MPAG concentration followed by an increased MPA concentration; therefore, IMPDH activity decreases. Diarrhea decreases the enterohepatic circulation of MPAG and consequently reduces MPA concentration. The IC50 for MPA exhibited a positive association with C-reactive protein. Dosage adjustment based on plasma MPA concentration is required especially for patients with renal dysfunction and/or diarrhea.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bmt.2017.213", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.5910252", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "53"
      }
    ], 
    "keywords": [
      "hematopoietic stem cell transplantation", 
      "stem cell transplantation", 
      "MPA concentrations", 
      "mycophenolic acid", 
      "MPA glucuronide", 
      "HCT patients", 
      "mycophenolate mofetil", 
      "cell transplantation", 
      "pharmacodynamic parameters", 
      "enterohepatic circulation", 
      "plasma MPA concentrations", 
      "C-reactive protein", 
      "first-order elimination", 
      "inosine-5'-monophosphate dehydrogenase (IMPDH) activity", 
      "one-compartment model", 
      "half maximal inhibitory concentration", 
      "MMF therapy", 
      "MPAG concentrations", 
      "renal dysfunction", 
      "MPA therapy", 
      "creatinine clearance", 
      "dosage adjustment", 
      "population pharmacokinetics", 
      "prospective data", 
      "program NONMEM", 
      "blood samples", 
      "patients", 
      "pharmacodynamic model", 
      "inhibitory concentration", 
      "transplantation", 
      "diarrhea", 
      "positive association", 
      "therapy", 
      "dehydrogenase activity", 
      "GVHD", 
      "mofetil", 
      "dysfunction", 
      "pharmacodynamics", 
      "inhibitory model", 
      "population", 
      "pharmacokinetics", 
      "activity decreases", 
      "NONMEM", 
      "glucuronide", 
      "circulation", 
      "clearance", 
      "prodrug", 
      "IC50", 
      "concentration", 
      "association", 
      "acid", 
      "adjustment", 
      "decrease", 
      "activity", 
      "protein", 
      "elimination", 
      "study", 
      "purpose", 
      "samples", 
      "data", 
      "model", 
      "parameters", 
      "simulations"
    ], 
    "name": "Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation", 
    "pagination": "44-51", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1092132023"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2017.213"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28991252"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2017.213", 
      "https://app.dimensions.ai/details/publication/pub.1092132023"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_718.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bmt.2017.213"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2017.213'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2017.213'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2017.213'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2017.213'


 

This table displays all metadata directly associated to this object as RDF triples.

271 TRIPLES      21 PREDICATES      108 URIs      90 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2017.213 schema:about N11bb28b32e4049f4aade7c3f4bbec6f8
2 N38bcf127ee2445d3a82d7a6d353e4fbf
3 N3cfbdb1aa80a4aeea92b32054b9005b3
4 N6ed25b27c2d445339871070cdc33a2b7
5 N89be7ce6be114c3e81900b17fd03a83a
6 N99d96437ea4249a79456726052b10d49
7 Na8ccd2b29c7b4e0e96a320062112c7fb
8 Na8f3f04fdc234c2db88f8f188154cf2e
9 Nda98480dddcf4b3f95f9b548281ac677
10 Nffd96cdc411c4d68b77f0ce9bd772363
11 anzsrc-for:11
12 anzsrc-for:1103
13 schema:author N624140b3c4f548899c15b52a45e8bd45
14 schema:citation sg:pub.10.1007/bf01113502
15 sg:pub.10.1007/s10928-007-9066-0
16 sg:pub.10.1007/s12185-011-0888-6
17 sg:pub.10.1007/s12185-012-1086-x
18 sg:pub.10.1007/s40620-016-0345-y
19 sg:pub.10.1023/a:1012299115260
20 sg:pub.10.1038/bmt.2014.258
21 sg:pub.10.1038/sj.clpt.6100347
22 sg:pub.10.1208/s12248-011-9255-z
23 sg:pub.10.2165/00003088-200746010-00002
24 schema:datePublished 2017-10-09
25 schema:datePublishedReg 2017-10-09
26 schema:description Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is used to suppress GvHD in patients undergoing hematopoietic stem cell transplantation (HCT). The purpose of this study was to construct a population pharmacokinetic and pharmacodynamic model in HCT patients for individualized MPA therapy. Blood samples were obtained from 49 HCT patients after starting MMF therapy. Population pharmacokinetic and pharmacodynamic parameters were obtained using the program NONMEM. MPA was described via a one-compartment model with a first-order elimination, and 30.9% of MPA glucuronide (MPAG) was found in the enterohepatic circulation. Inosine-5′-monophosphate dehydrogenase (IMPDH) activity was modeled as a maximal inhibitory model with a half-maximal inhibitory concentration (IC50) of 3.59 μg/mL against MPA concentrations. Simulations based on the obtained pharmacokinetic and pharmacodynamic parameters revealed that decreased creatinine clearance increases the MPAG concentration followed by an increased MPA concentration; therefore, IMPDH activity decreases. Diarrhea decreases the enterohepatic circulation of MPAG and consequently reduces MPA concentration. The IC50 for MPA exhibited a positive association with C-reactive protein. Dosage adjustment based on plasma MPA concentration is required especially for patients with renal dysfunction and/or diarrhea.
27 schema:genre article
28 schema:isAccessibleForFree true
29 schema:isPartOf Na844700b69f344b38a49d51be8fe4dc7
30 Nd7f9576d73ef4463a758017134a0bbf3
31 sg:journal.1096890
32 schema:keywords C-reactive protein
33 GVHD
34 HCT patients
35 IC50
36 MMF therapy
37 MPA concentrations
38 MPA glucuronide
39 MPA therapy
40 MPAG concentrations
41 NONMEM
42 acid
43 activity
44 activity decreases
45 adjustment
46 association
47 blood samples
48 cell transplantation
49 circulation
50 clearance
51 concentration
52 creatinine clearance
53 data
54 decrease
55 dehydrogenase activity
56 diarrhea
57 dosage adjustment
58 dysfunction
59 elimination
60 enterohepatic circulation
61 first-order elimination
62 glucuronide
63 half maximal inhibitory concentration
64 hematopoietic stem cell transplantation
65 inhibitory concentration
66 inhibitory model
67 inosine-5'-monophosphate dehydrogenase (IMPDH) activity
68 model
69 mofetil
70 mycophenolate mofetil
71 mycophenolic acid
72 one-compartment model
73 parameters
74 patients
75 pharmacodynamic model
76 pharmacodynamic parameters
77 pharmacodynamics
78 pharmacokinetics
79 plasma MPA concentrations
80 population
81 population pharmacokinetics
82 positive association
83 prodrug
84 program NONMEM
85 prospective data
86 protein
87 purpose
88 renal dysfunction
89 samples
90 simulations
91 stem cell transplantation
92 study
93 therapy
94 transplantation
95 schema:name Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation
96 schema:pagination 44-51
97 schema:productId N6e13a4e3c73347488d0a89144e422b60
98 N76a4a2cf584444c29df49b5c0be61c97
99 N8a2494a072fe43cd85b3ee98ab1ed1eb
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092132023
101 https://doi.org/10.1038/bmt.2017.213
102 schema:sdDatePublished 2022-12-01T06:35
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher Nab4b2c8cd857431bb1d5041a2974599b
105 schema:url https://doi.org/10.1038/bmt.2017.213
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N022b5612f4fb49cdbd69785505486a70 rdf:first sg:person.0743352217.37
110 rdf:rest Na36999b98bc84674b3c16f52984d6c0a
111 N11bb28b32e4049f4aade7c3f4bbec6f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Adult
113 rdf:type schema:DefinedTerm
114 N38bcf127ee2445d3a82d7a6d353e4fbf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Young Adult
116 rdf:type schema:DefinedTerm
117 N3cfbdb1aa80a4aeea92b32054b9005b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N555e2d1e276c4a85b30f6d2b497838f8 rdf:first sg:person.01300424310.00
121 rdf:rest N5a0a9bedcb56478fbc92c06bfe1e73fa
122 N5a0a9bedcb56478fbc92c06bfe1e73fa rdf:first sg:person.0732346503.61
123 rdf:rest Nce1defa47cc34438a311d38bfbe2cd75
124 N624140b3c4f548899c15b52a45e8bd45 rdf:first sg:person.01046575103.12
125 rdf:rest N6c66d12f53b24d2b99f0cb2c9a007f0f
126 N6c66d12f53b24d2b99f0cb2c9a007f0f rdf:first sg:person.01253561205.99
127 rdf:rest N555e2d1e276c4a85b30f6d2b497838f8
128 N6e13a4e3c73347488d0a89144e422b60 schema:name pubmed_id
129 schema:value 28991252
130 rdf:type schema:PropertyValue
131 N6ed25b27c2d445339871070cdc33a2b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Aged
133 rdf:type schema:DefinedTerm
134 N76a4a2cf584444c29df49b5c0be61c97 schema:name doi
135 schema:value 10.1038/bmt.2017.213
136 rdf:type schema:PropertyValue
137 N89be7ce6be114c3e81900b17fd03a83a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Male
139 rdf:type schema:DefinedTerm
140 N8a2494a072fe43cd85b3ee98ab1ed1eb schema:name dimensions_id
141 schema:value pub.1092132023
142 rdf:type schema:PropertyValue
143 N99d96437ea4249a79456726052b10d49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Middle Aged
145 rdf:type schema:DefinedTerm
146 Na36999b98bc84674b3c16f52984d6c0a rdf:first sg:person.01303570015.74
147 rdf:rest rdf:nil
148 Na844700b69f344b38a49d51be8fe4dc7 schema:volumeNumber 53
149 rdf:type schema:PublicationVolume
150 Na8ccd2b29c7b4e0e96a320062112c7fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Prospective Studies
152 rdf:type schema:DefinedTerm
153 Na8f3f04fdc234c2db88f8f188154cf2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Hematopoietic Stem Cell Transplantation
155 rdf:type schema:DefinedTerm
156 Nab4b2c8cd857431bb1d5041a2974599b schema:name Springer Nature - SN SciGraph project
157 rdf:type schema:Organization
158 Nce1defa47cc34438a311d38bfbe2cd75 rdf:first sg:person.014305050033.92
159 rdf:rest Nf36d6576b7e7469690577e921338d721
160 Nd7f9576d73ef4463a758017134a0bbf3 schema:issueNumber 1
161 rdf:type schema:PublicationIssue
162 Nda98480dddcf4b3f95f9b548281ac677 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Female
164 rdf:type schema:DefinedTerm
165 Ndbaee17fe37b4ea9936b6a998d6c5d32 rdf:first sg:person.0666225507.36
166 rdf:rest N022b5612f4fb49cdbd69785505486a70
167 Nf36d6576b7e7469690577e921338d721 rdf:first sg:person.0703767356.41
168 rdf:rest Ndbaee17fe37b4ea9936b6a998d6c5d32
169 Nffd96cdc411c4d68b77f0ce9bd772363 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Mycophenolic Acid
171 rdf:type schema:DefinedTerm
172 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
173 schema:name Medical and Health Sciences
174 rdf:type schema:DefinedTerm
175 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
176 schema:name Clinical Sciences
177 rdf:type schema:DefinedTerm
178 sg:grant.5910252 http://pending.schema.org/fundedItem sg:pub.10.1038/bmt.2017.213
179 rdf:type schema:MonetaryGrant
180 sg:journal.1096890 schema:issn 0268-3369
181 1476-5365
182 schema:name Bone Marrow Transplantation
183 schema:publisher Springer Nature
184 rdf:type schema:Periodical
185 sg:person.01046575103.12 schema:affiliation grid-institutes:grid.411217.0
186 schema:familyName Yoshimura
187 schema:givenName K
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046575103.12
189 rdf:type schema:Person
190 sg:person.01253561205.99 schema:affiliation grid-institutes:grid.411102.7
191 schema:familyName Yano
192 schema:givenName I
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253561205.99
194 rdf:type schema:Person
195 sg:person.01300424310.00 schema:affiliation grid-institutes:grid.411217.0
196 schema:familyName Yamamoto
197 schema:givenName T
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300424310.00
199 rdf:type schema:Person
200 sg:person.01303570015.74 schema:affiliation grid-institutes:grid.411217.0
201 schema:familyName Matsubara
202 schema:givenName K
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303570015.74
204 rdf:type schema:Person
205 sg:person.014305050033.92 schema:affiliation grid-institutes:grid.411217.0
206 schema:familyName Isomoto
207 schema:givenName Y
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014305050033.92
209 rdf:type schema:Person
210 sg:person.0666225507.36 schema:affiliation grid-institutes:grid.258799.8
211 schema:familyName Kondo
212 schema:givenName T
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666225507.36
214 rdf:type schema:Person
215 sg:person.0703767356.41 schema:affiliation grid-institutes:grid.411217.0
216 schema:familyName Yonezawa
217 schema:givenName A
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703767356.41
219 rdf:type schema:Person
220 sg:person.0732346503.61 schema:affiliation grid-institutes:grid.411217.0
221 schema:familyName Kawanishi
222 schema:givenName M
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732346503.61
224 rdf:type schema:Person
225 sg:person.0743352217.37 schema:affiliation grid-institutes:grid.258799.8
226 schema:familyName Takaori-Kondo
227 schema:givenName A
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743352217.37
229 rdf:type schema:Person
230 sg:pub.10.1007/bf01113502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044213416
231 https://doi.org/10.1007/bf01113502
232 rdf:type schema:CreativeWork
233 sg:pub.10.1007/s10928-007-9066-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023254119
234 https://doi.org/10.1007/s10928-007-9066-0
235 rdf:type schema:CreativeWork
236 sg:pub.10.1007/s12185-011-0888-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049134449
237 https://doi.org/10.1007/s12185-011-0888-6
238 rdf:type schema:CreativeWork
239 sg:pub.10.1007/s12185-012-1086-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049970375
240 https://doi.org/10.1007/s12185-012-1086-x
241 rdf:type schema:CreativeWork
242 sg:pub.10.1007/s40620-016-0345-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1026969484
243 https://doi.org/10.1007/s40620-016-0345-y
244 rdf:type schema:CreativeWork
245 sg:pub.10.1023/a:1012299115260 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050934479
246 https://doi.org/10.1023/a:1012299115260
247 rdf:type schema:CreativeWork
248 sg:pub.10.1038/bmt.2014.258 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041000870
249 https://doi.org/10.1038/bmt.2014.258
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/sj.clpt.6100347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022424851
252 https://doi.org/10.1038/sj.clpt.6100347
253 rdf:type schema:CreativeWork
254 sg:pub.10.1208/s12248-011-9255-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1035687095
255 https://doi.org/10.1208/s12248-011-9255-z
256 rdf:type schema:CreativeWork
257 sg:pub.10.2165/00003088-200746010-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003506752
258 https://doi.org/10.2165/00003088-200746010-00002
259 rdf:type schema:CreativeWork
260 grid-institutes:grid.258799.8 schema:alternateName Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan
261 schema:name Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan
262 rdf:type schema:Organization
263 grid-institutes:grid.411102.7 schema:alternateName Department of Pharmacy, Kobe University Hospital, Chuo-ku, Kobe, Japan
264 schema:name Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan
265 Department of Clinical Pharmacy and Education, Graduate School of Pharmaceutical Science, Kyoto University, Sakyo-ku, Kyoto, Japan
266 Department of Pharmacy, Kobe University Hospital, Chuo-ku, Kobe, Japan
267 rdf:type schema:Organization
268 grid-institutes:grid.411217.0 schema:alternateName Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan
269 schema:name Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan
270 Department of Clinical Pharmacy and Education, Graduate School of Pharmaceutical Science, Kyoto University, Sakyo-ku, Kyoto, Japan
271 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...